Bat
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria,
Latin Name:
Rhinolophus sinicus
Tested tissues: Lung,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0004 | 2021.04 | 10X Genomics | Lung | Normal | 11838 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Ebola virus |
Lung-ATII : 95.80% ; Lung-Secretory cells : 62.15% ; Lung-Ciliated cells : 56.69% ; Lung-Macrophages : 43.73% ; Lung-ATI : 27.11% ; Lung-Macrophages : 45.27% ; Lung-Fibroblasts : 13.91% ; Lung-B cells : 13.42% ; Lung-Macrophages : 37.84% ; Lung-Secretory cells : 27.98% ; Lung-Fibroblasts : 13.91% ; Lung-uk1 : 9.88% ; Lung-Ciliated cells : 8.89% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Lung-ATII : 77.86% ; Lung-Secretory cells : 59.95% ; Lung-Macrophages : 58.02% ; Lung-ATI : 39.46% ; Lung-B cells : 38.50% ; Lung-Macrophages : 45.27% ; Lung-Fibroblasts : 13.91% ; Lung-B cells : 13.42% ; Lung-Macrophages : 35.46% ; Lung-Endothelial cells : 19.99% ; Lung-uk1 : 18.36% ; Lung-Secretory cells : 16.64% ; Lung-ATII : 15.84% ; |
|
Influenza A virus |
Lung-Macrophages : 74.35% ; Lung-Secretory cells : 54.65% ; Lung-ATII : 47.42% ; Lung-Ciliated cells : 42.58% ; Lung-ATI : 37.95% ; Lung-Fibroblasts : 71.50% ; Lung-Mesothelial cells : 43.33% ; Lung-B cells : 35.78% ; Lung-Ciliated cells : 28.18% ; Lung-Macrophages : 24.11% ; Lung-Macrophages : 47.86% ; Lung-ATI : 33.13% ; Lung-Ciliated cells : 32.23% ; Lung-ATII : 21.09% ; Lung-Endothelial cells : 19.75% ; Lung-Secretory cells : 31.40% ; Lung-B cells : 28.43% ; Lung-ATII : 25.48% ; Lung-Mesothelial cells : 24.56% ; Lung-Ciliated cells : 21.93% ; |
|
Vesicular stomatitis virus |
Lung-Macrophages : 74.35% ; Lung-Secretory cells : 54.65% ; Lung-ATII : 47.42% ; Lung-Ciliated cells : 42.58% ; Lung-ATI : 37.95% ; |
|
Rhinovirus C |
Lung-Ciliated cells : 62.99% ; Lung-Brush cells : 15.22% ; |
|
Human alphaherpesvirus 1 |
Lung-Mesothelial cells : 58.07% ; Lung-Ciliated cells : 57.20% ; Lung-Secretory cells : 55.87% ; Lung-Brush cells : 45.65% ; Lung-ATII : 29.77% ; Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-ATII : 29.39% ; Lung-Secretory cells : 15.25% ; Lung-Ciliated cells : 13.16% ; Lung-Macrophages : 12.54% ; |
|
Foot-and-mouth disease virus |
Lung-Mesothelial cells : 58.07% ; Lung-Ciliated cells : 57.20% ; Lung-Secretory cells : 55.87% ; Lung-Brush cells : 45.65% ; Lung-ATII : 29.77% ; Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-Endothelial cells : 21.95% ; Lung-B cells : 12.30% ; Lung-uk1 : 9.72% ; Lung-ATI : 10.44% ; |
|
Murine norovirus |
Lung-Macrophages : 55.85% ; Lung-uk1 : 8.80% ; |
|
Human mastadenovirus B | |
|
Coxsackievirus A10 |
Lung-Ciliated cells : 47.58% ; Lung-ATI : 22.19% ; Lung-Brush cells : 21.74% ; Lung-Secretory cells : 19.49% ; Lung-Fibroblasts : 12.71% ; |
|
Adeno-associated virus - 2 |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; Lung-Secretory cells : 40.13% ; Lung-Ciliated cells : 34.36% ; Lung-ATII : 27.10% ; Lung-Macrophages : 19.69% ; Lung-Brush cells : 16.30% ; Lung-Endothelial cells : 21.95% ; Lung-B cells : 12.30% ; Lung-uk1 : 9.72% ; Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Human gammaherpesvirus 4 |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; |
|
Human betaherpesvirus 5 |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; Lung-Secretory cells : 31.40% ; Lung-B cells : 28.43% ; Lung-ATII : 25.48% ; Lung-Mesothelial cells : 24.56% ; Lung-Ciliated cells : 21.93% ; Lung-ATI : 10.44% ; |
|
Equid alphaherpesvirus 1 | |
|
Human rotavirus strain WA | |
|
Echovirus E8 |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; |
|
Echovirus E1 |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; |
|
Human parvovirus B19 | |
|
Mammalian orthoreovirus | |
|
Human metapneumovirus | |
|
Simian rotavirus A strain RRV |
Lung-Macrophages : 47.30% ; Lung-ATI : 34.94% ; Lung-T cells : 27.15% ; Lung-Fibroblasts : 26.96% ; Lung-ATII : 22.04% ; Lung-Macrophages : 46.74% ; Lung-Ciliated cells : 37.06% ; Lung-B cells : 36.26% ; Lung-ATII : 36.16% ; Lung-Brush cells : 34.78% ; Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-Brush cells : 31.52% ; Lung-Secretory cells : 29.20% ; Lung-ATII : 25.67% ; Lung-Ciliated cells : 22.05% ; Lung-Endothelial cells : 17.01% ; Lung-ATI : 10.44% ; |
|
Enterovirus A71 |
Lung-ATII : 45.80% ; Lung-Ciliated cells : 33.63% ; Lung-Secretory cells : 16.97% ; Lung-B cells : 12.94% ; Lung-uk1 : 11.42% ; |
|
Coxsackievirus A16 |
Lung-ATII : 45.80% ; Lung-Ciliated cells : 33.63% ; Lung-Secretory cells : 16.97% ; Lung-B cells : 12.94% ; Lung-uk1 : 11.42% ; |
|
Human mastadenovirus C |
Lung-ATI : 45.58% ; Lung-Mesothelial cells : 37.89% ; Lung-Ciliated cells : 32.34% ; Lung-Brush cells : 20.65% ; Lung-B cells : 17.89% ; Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Marburg marburgvirus | |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Dengue virus |
Lung-Macrophages : 45.27% ; Lung-Fibroblasts : 13.91% ; Lung-B cells : 13.42% ; Lung-Macrophages : 28.03% ; Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; Lung-Macrophages : 17.94% ; |
|
Lassa mammarenavirus |
Lung-Macrophages : 45.27% ; Lung-Fibroblasts : 13.91% ; Lung-B cells : 13.42% ; Lung-Macrophages : 39.45% ; Lung-ATII : 26.34% ; Lung-Secretory cells : 23.33% ; Lung-Ciliated cells : 22.89% ; Lung-Mesothelial cells : 19.65% ; Lung-Ciliated cells : 29.81% ; Lung-ATI : 21.08% ; Lung-B cells : 20.29% ; Lung-Secretory cells : 20.15% ; Lung-Mesothelial cells : 20.00% ; |
|
Zika virus |
Lung-Macrophages : 45.27% ; Lung-Fibroblasts : 13.91% ; Lung-B cells : 13.42% ; |
|
Varicella Zoster Virus |
Lung-Macrophages : 44.57% ; Lung-Secretory cells : 25.20% ; Lung-ATII : 24.05% ; Lung-Ciliated cells : 20.64% ; Lung-B cells : 19.17% ; |
|
Human alphaherpesvirus 3 |
Lung-Macrophages : 44.57% ; Lung-Secretory cells : 25.20% ; Lung-ATII : 24.05% ; Lung-Ciliated cells : 20.64% ; Lung-B cells : 19.17% ; |
|
Bovine leukemia virus |
Lung-Macrophages : 43.45% ; Lung-B cells : 42.65% ; Lung-ATII : 38.65% ; Lung-Secretory cells : 35.40% ; Lung-uk1 : 33.80% ; |
|
Polytropic murine leukemia virus |
Lung-Macrophages : 41.56% ; Lung-ATII : 24.24% ; Lung-Ciliated cells : 22.22% ; Lung-Secretory cells : 22.19% ; Lung-Fibroblasts : 21.50% ; |
|
Xenotropic murine leukemia virus |
Lung-Macrophages : 41.56% ; Lung-ATII : 24.24% ; Lung-Ciliated cells : 22.22% ; Lung-Secretory cells : 22.19% ; Lung-Fibroblasts : 21.50% ; |
|
Coxsackievirus A9 | |
|
West Nile virus | |
|
Human gammaherpesvirus 8 | |
|
Coxsackievirus B1 |
Lung-Macrophages : 40.43% ; Lung-ATI : 33.73% ; Lung-Secretory cells : 25.77% ; Lung-B cells : 22.84% ; Lung-Ciliated cells : 20.58% ; Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Human parechovirus 1 | |
|
Hepacivirus C |
Lung-Macrophages : 35.46% ; Lung-Endothelial cells : 19.99% ; Lung-uk1 : 18.36% ; Lung-Secretory cells : 16.64% ; Lung-ATII : 15.84% ; Lung-Secretory cells : 31.40% ; Lung-B cells : 28.43% ; Lung-ATII : 25.48% ; Lung-Mesothelial cells : 24.56% ; Lung-Ciliated cells : 21.93% ; Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; Lung-Macrophages : 23.55% ; Lung-Fibroblasts : 14.68% ; Lung-Mesothelial cells : 13.33% ; Lung-SMCs : 10.96% ; Lung-uk1 : 10.49% ; Lung-Ciliated cells : 19.01% ; Lung-Secretory cells : 17.54% ; Lung-Macrophages : 17.94% ; Lung-ATI : 12.15% ; |
|
Porcine epidemic diarrhea virus |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Infectious bronchitis virus |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Human coronavirus 229E |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Transmissible gastroenteritis virus |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Canine coronavirus |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Feline coronavirus |
Lung-ATII : 33.97% ; Lung-ATI : 10.54% ; Lung-uk1 : 9.10% ; |
|
Simian sarcoma-associated virus |
Lung-Macrophages : 32.10% ; Lung-ATI : 11.45% ; Lung-Ciliated cells : 10.80% ; Lung-T cells : 9.58% ; Lung-Secretory cells : 9.38% ; |
|
Feline leukemia virus strain B/lambda-B1 | |
|
Gibbon ape leukemia virus | |
|
Feline calicivirus |
Lung-Brush cells : 31.52% ; Lung-Secretory cells : 29.20% ; Lung-ATII : 25.67% ; Lung-Ciliated cells : 22.05% ; Lung-Endothelial cells : 17.01% ; |
|
Middle East respiratory syndrome-related coronavirus |
Lung-Mesothelial cells : 30.18% ; Lung-T cells : 21.16% ; Lung-ATII : 12.60% ; |
|
Oliveros mammarenavirus |
Lung-Ciliated cells : 29.81% ; Lung-ATI : 21.08% ; Lung-B cells : 20.29% ; Lung-Secretory cells : 20.15% ; Lung-Mesothelial cells : 20.00% ; |
|
Latino mammarenavirus |
Lung-Ciliated cells : 29.81% ; Lung-ATI : 21.08% ; Lung-B cells : 20.29% ; Lung-Secretory cells : 20.15% ; Lung-Mesothelial cells : 20.00% ; |
|
Suid alphaherpesvirus 1 |
Lung-ATII : 29.39% ; Lung-Secretory cells : 15.25% ; Lung-Ciliated cells : 13.16% ; Lung-Macrophages : 12.54% ; |
|
Human alphaherpesvirus 2 |
Lung-ATII : 29.39% ; Lung-Secretory cells : 15.25% ; Lung-Ciliated cells : 13.16% ; Lung-Macrophages : 12.54% ; |
|
Porcine reproductive and respiratory syndrome virus |
Lung-Macrophages : 27.75% ; |
|
Enterovirus B |
Lung-Macrophages : 26.00% ; Lung-B cells : 12.62% ; Lung-Secretory cells : 10.28% ; Lung-uk1 : 9.26% ; Lung-Ciliated cells : 9.22% ; |
|
Argentinian mammarenavirus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Feline panleukopenia virus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Canine parvovirus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Machupo mammarenavirus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Mouse mammary tumor virus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Guanarito mammarenavirus |
Lung-Macrophages : 24.46% ; Lung-B cells : 14.54% ; Lung-Secretory cells : 13.95% ; Lung-SMCs : 12.33% ; Lung-ATII : 11.64% ; |
|
Hendra henipavirus |
Lung-Brush cells : 23.91% ; Lung-Endothelial cells : 10.29% ; |
|
Nipah henipavirus |
Lung-Brush cells : 23.91% ; Lung-Endothelial cells : 10.29% ; |
|
Amphotropic murine leukemia virus |
Lung-Ciliated cells : 22.44% ; Lung-Brush cells : 18.48% ; Lung-Secretory cells : 17.13% ; Lung-ATII : 16.22% ; Lung-B cells : 14.54% ; |
|
Baboon endogenous virus strain M7 |
Lung-Secretory cells : 22.10% ; Lung-Macrophages : 18.57% ; Lung-Ciliated cells : 11.47% ; Lung-ATII : 8.59% ; |
|
Simian type D retrovirus -Tsukuba |
Lung-Secretory cells : 22.10% ; Lung-Macrophages : 18.57% ; Lung-Ciliated cells : 11.47% ; |
|
Feline endogenous virus RD114 |
Lung-Secretory cells : 22.10% ; Lung-Macrophages : 18.57% ; Lung-Ciliated cells : 11.47% ; |
|
Adeno-associated virus - 3 |
Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Adeno-associated virus - 8 |
Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Classical swine fever virus | |
|
Adeno-associated virus 9 |
Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Sindbis virus |
Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Venezuelan equine encephalitis virus |
Lung-Ciliated cells : 21.71% ; Lung-SMCs : 15.07% ; Lung-Mesothelial cells : 11.23% ; Lung-Secretory cells : 11.01% ; Lung-Macrophages : 10.65% ; |
|
Human mastadenovirus A |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Coxsackievirus B3 | |
|
Coxsackievirus B4 |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Human mastadenovirus F |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Coxsackievirus B5 | |
|
Coxsackievirus B6 |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Human mastadenovirus D | |
|
Coxsackievirus B2 |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Human mastadenovirus E |
Lung-Ciliated cells : 20.98% ; Lung-Mesothelial cells : 20.70% ; Lung-Secretory cells : 12.32% ; Lung-ATII : 9.64% ; Lung-ATI : 9.44% ; |
|
Bovine viral diarrhea virus 1 |
Lung-Ciliated cells : 20.58% ; Lung-Endothelial cells : 14.10% ; |
|
Human betaherpesvirus 6 |
Lung-Ciliated cells : 20.58% ; Lung-Endothelial cells : 14.10% ; |
|
Measles morbillivirus | |
|
Human betaherpesvirus 6A |
Lung-Ciliated cells : 20.58% ; Lung-Endothelial cells : 14.10% ; |
|
Human papillomavirus type 16 |
Lung-Endothelial cells : 16.84% ; Lung-T cells : 13.77% ; Lung-Brush cells : 9.78% ; |
|
Echovirus E12 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E13 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E11 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E20 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E21 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Human enterovirus 70 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Enterovirus D68 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E29 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E33 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E7 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Coxsackievirus A21 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Echovirus E6 |
Lung-ATII : 15.84% ; Lung-Mesothelial cells : 13.51% ; |
|
Feline immunodeficiency virus |
Lung-T cells : 15.77% ; |
|
Human immunodeficiency virus 1 |
Lung-T cells : 15.77% ; |
|
Human immunodeficiency virus 2 |
Lung-T cells : 15.77% ; |
|
Encephalomyocarditis virus |
Lung-Macrophages : 15.63% ; Lung-Endothelial cells : 14.69% ; |
|
Hepatitis E virus |
Lung-Mesothelial cells : 14.39% ; Lung-ATII : 14.03% ; Lung-Ciliated cells : 10.69% ; Lung-ATI : 10.44% ; |
|
Feline leukemia virus strain C/FA27 |
Lung-Ciliated cells : 12.60% ; Lung-Secretory cells : 11.66% ; Lung-Macrophages : 9.53% ; |
|
Jaagsiekte sheep retrovirus |
Lung-Endothelial cells : 12.02% ; |
|
Hantaan orthohantavirus |
Lung-ATI : 10.44% ; |
|
Canine morbillivirus |
Lung-T cells : 10.38% ; |
|
Phocine morbillivirus |
Lung-T cells : 10.38% ; |
|
Rinderpest morbillivirus |
Lung-T cells : 10.38% ; |
|
Porcine endogenous retrovirus A |
Lung-B cells : 8.95% ; |
|
Ecotropic murine leukemia virus |
Lung-Brush cells : 8.70% ; |